PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

CompletedOBSERVATIONAL
Enrollment

1,773

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Melanoma
Trial Locations (17)

9

Local Institution, Dublin

1090

Local Institution, Brussels

4010

Local Institution, Linz

4032

Local Institution, Debrecen

5000

Local Institution, Odense C

8091

Local Institution, Zurich

21614

Elbe Klinikum Buxtehude, Buxtehude

46009

Local Institution, Valencia

76000

Local Institution, Rouen

80131

Local Institution, Napoli

115478

Local Institution, Moscow

02284-5640

Local Institution, Boston

02284

Outcome Sciences Inc Dba Outcome, Boston

100 34

Local Institution, Prague

1066 CX

Local Institution, Amsterdam

0310

Local Institution, Oslo

GU2 7XX

Local Institution, Guildford

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY